Agneza Marija Pasini1, Josip Marjanović2, Goran Roić1, Nikola Dukarić1, Ana Tripalo Batoš1, Zoran Bahtijarević1, Alenka Gagro3,4,5. 1. Children's Hospital Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia. 2. Department of Radiology, Royal Belfast Hospital for Sick Children, Belfast, UK. 3. Children's Hospital Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia. alenka.gagro@gmail.com. 4. Faculty of Medicine, Josip Juraj Strossmayer, University of Osijek, Osijek, Croatia. alenka.gagro@gmail.com. 5. Department of Pulmonology, Allergology, Immunology and Rheumatology, Department of Pediatrics, Children's Hospital Zagreb, Zagreb, Croatia. alenka.gagro@gmail.com.
Abstract
Magnetic resonance imaging (MRI) in preschool children is often challenging due to excessive motion artifacts. Sedation or general anesthesia (GA) is commonly used to prevent children from moving in the MRI scanner, with increased risk for cardiopulmonary complications and requirement for skilled personnel. Herein, we investigated whether oral melatonin, a natural hormone implicated in circadian rhythm regulation, could be used as an alternative sedation method prior to the MRI in preschool children with musculoskeletal problems. Fifteen children with suspected juvenile idiopathic arthritis underwent a total of 16 MRI examinations following administration of 10 mg of oral melatonin; satisfactory images were obtained in all but one case, with no adverse events. CONCLUSION: The use of melatonin before the musculoskeletal MRI in preschool children is an effective, safe, and inexpensive alternative to standard sedation and general anesthesia in preventing motion artifacts. What is Known: • Magnetic resonance imaging (MRI) is a well-recognized diagnostic method to visualize synovial inflammation and changes of cartilage and bone in juvenile idiopathic arthritis. • MRI examination requires sedation or general anesthesia to ensure immobility in children who are uncooperative. What is New: • Melatonin without sleep deprivation is efficacious and safe alternative to conventional sedation and general anesthesia before the musculoskeletal contrast-enhanced MRI in preschool children with JIA with timely insertion of intravenous cannula.
Magnetic resonance imaging (MRI) in preschool children is often challenging due to excessive motion artifacts. Sedation or general anesthesia (GA) is commonly used to prevent children from moving in the MRI scanner, with increased risk for cardiopulmonary complications and requirement for skilled personnel. Herein, we investigated whether oral melatonin, a natural hormone implicated in circadian rhythm regulation, could be used as an alternative sedation method prior to the MRI in preschool children with musculoskeletal problems. Fifteen children with suspected juvenile idiopathic arthritis underwent a total of 16 MRI examinations following administration of 10 mg of oral melatonin; satisfactory images were obtained in all but one case, with no adverse events. CONCLUSION: The use of melatonin before the musculoskeletal MRI in preschool children is an effective, safe, and inexpensive alternative to standard sedation and general anesthesia in preventing motion artifacts. What is Known: • Magnetic resonance imaging (MRI) is a well-recognized diagnostic method to visualize synovial inflammation and changes of cartilage and bone in juvenile idiopathic arthritis. • MRI examination requires sedation or general anesthesia to ensure immobility in children who are uncooperative. What is New: • Melatonin without sleep deprivation is efficacious and safe alternative to conventional sedation and general anesthesia before the musculoskeletal contrast-enhanced MRI in preschool children with JIA with timely insertion of intravenous cannula.
Authors: Henrica M A de Bie; Maria Boersma; Mike P Wattjes; Sofie Adriaanse; R Jeroen Vermeulen; Kim J Oostrom; Jaap Huisman; Dick J Veltman; Henriette A Delemarre-Van de Waal Journal: Eur J Pediatr Date: 2010-03-13 Impact factor: 3.183
Authors: A N Colebatch-Bourn; C J Edwards; P Collado; M-A D'Agostino; R Hemke; S Jousse-Joulin; M Maas; A Martini; E Naredo; M Østergaard; M Rooney; N Tzaribachev; M A van Rossum; J Vojinovic; P G Conaghan; C Malattia Journal: Ann Rheum Dis Date: 2015-08-05 Impact factor: 19.103
Authors: S Picone; P Ariganello; V Mondì; F Di Palma; L Martini; S Marziali; G Fariello; P Paolillo Journal: Ital J Pediatr Date: 2019-09-23 Impact factor: 2.638